Skip to NavigationSkip to content

Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products

Published date: 
20/07/2011

Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet clinical needs based on the MC2 Biotek’s proprietary PAD™ drug delivery technology.

Jesper J. Lange, President of MC2 Biotek Group comments:

 

“We are very pleased to have entered into this licence and collaboration agreement with Moorfields Pharmaceuticals, a division of Moorfield Eye Hospital NHS Foundation Trust, one of the world’s leading ophthalmic hospitals. The team at Moorfields Pharmaceuticals has a deep insight into unmet clinical needs of patients and they represent an innovative and forward looking mindset. I am confident that our joint efforts will bring novel and better ophthalmic products to the market to help improve the lives of patients. The collaboration is an important step in MC2 Biotek’s efforts to expand applications of our PAD™ drug delivery technology from dermatology into ophthalmology and allow patients and our partners to benefit from our technology and formulation expertise.”

 

About Moorfields Pharmaceuticals

 

Originally set-up as a dedicated manufacturing facility for the world-renowned Moorfields Eye Hospital, it has taken Moorfields Pharmaceuticals less than 6 years to establish itself as a leading specialist manufacturer of ophthalmic medicines and Specials.

 

From a purpose-built manufacturing facility close to London’s financial district, Moorfields Pharmaceuticals operates a highly unique business for the production of the widest range of ophthalmic drugs available anywhere in the UK.

 

About MC2 Biotek Group

MC2 Biotek Group is a Danish, privately held biotechnology group. Its business areas comprise: Oral Anti-Diabetics, 3D Tissue Culture, Drug Delivery Solutions, Skin Care and Food Supplements.

The Drug Delivery Solutions business area is focused on dermatology, ophthalmology and oral delivery and is based in Leatherhead, UK.

 

For further information, please contact:

 

Lyn Wallace at Wallace HCL via email: lyn@wallacehcl.com or by phone: +44 (0) 20 8995 5354

 

MC2 Biotek Group, Bøge Alle 5, 2970 Hørsholm, Denmark, www.mc2biotek.com

Phone: (+45) 20 18 22 22

 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches